NCT05099978 2024-09-04
A-TRAIN
National Cancer Center, Japan
Unknown
Clinical Trials
16 trialsNCT05597527 2022-10-28
Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05523804 2022-08-31
GO SOAR2
NHS Grampian
Unknown
NCT01611766 2021-06-10
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
Shanghai Gynecologic Oncology Group
Phase 3 Unknown
NCT03150121 2020-02-26
BEDOCA
Sheba Medical Center
Phase NA Unknown
NCT03942068 2019-05-08
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT03412526 2019-04-04
Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian
Sheba Medical Center
Phase 2 Unknown
NCT03846856 2019-04-04
The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance
Hillel Yaffe Medical Center
Unknown
NCT03547375 2018-06-06
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Anhui Provincial Hospital
Phase 2 Unknown
NCT02595021 2016-07-26
Total/Subtotal Colectomy in Ovarian Cancer
Shanghai Gynecologic Oncology Group
Phase 2 Unknown
NCT02711865 2016-03-17
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
Hillel Yaffe Medical Center
Unknown
NCT00532194 2015-09-23
ICON6
Medical Research Council
Phase 3 Unknown
NCT01823731 2013-06-05
A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index
National Cancer Center, Korea
Unknown
NCT01654146 2012-07-31
ICON8
Medical Research Council
Phase 3 Unknown
NCT01576744 2012-06-04
FHE4
Turku University Hospital
Unknown
NCT00533299 2007-09-21
Hydralazine Valproate for Ovarian Cancer
National Institute of Cancerología
Phase 3 Unknown